PL1599211T3 - Zastosowanie izorhamnetyny do leczenia nastrojów i chorób depresyjnych - Google Patents

Zastosowanie izorhamnetyny do leczenia nastrojów i chorób depresyjnych

Info

Publication number
PL1599211T3
PL1599211T3 PL04716231T PL04716231T PL1599211T3 PL 1599211 T3 PL1599211 T3 PL 1599211T3 PL 04716231 T PL04716231 T PL 04716231T PL 04716231 T PL04716231 T PL 04716231T PL 1599211 T3 PL1599211 T3 PL 1599211T3
Authority
PL
Poland
Prior art keywords
treatment
isorhamnetine
moods
depressive diseases
depressive
Prior art date
Application number
PL04716231T
Other languages
English (en)
Inventor
Shyam Sunder Chatterjee
Michael Nöldner
Karl Schötz
Original Assignee
Dr Willmar Schwabe Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10315022A external-priority patent/DE10315022A1/de
Priority claimed from DE10350194A external-priority patent/DE10350194B4/de
Application filed by Dr Willmar Schwabe Gmbh & Co Kg filed Critical Dr Willmar Schwabe Gmbh & Co Kg
Publication of PL1599211T3 publication Critical patent/PL1599211T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL04716231T 2003-03-03 2004-03-02 Zastosowanie izorhamnetyny do leczenia nastrojów i chorób depresyjnych PL1599211T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10309235 2003-03-03
DE10315022A DE10315022A1 (de) 2003-03-03 2003-04-02 Verwendung von Rutin und Isorhamnetin zur Behandlung von depressiven Verstimmungen und Erkrankungen sowie bei anderen affektiven Störungen
DE10350194A DE10350194B4 (de) 2003-10-28 2003-10-28 Verwendung von Extrakten aus Opuntien zur Behandlung von depressiven Verstimmungen und Erkrankungen
PCT/EP2004/002085 WO2004078189A1 (de) 2003-03-03 2004-03-02 Verwendung von rutin und isorhamnetin zur behandlung von depressiven verstimmungen und erkrankungen sowei bei anderen affektiven störungen
EP04716231A EP1599211B1 (de) 2003-03-03 2004-03-02 Verwendung von isorhamnetin zur behandlung von depressiven verstimmungen und erkrankungen

Publications (1)

Publication Number Publication Date
PL1599211T3 true PL1599211T3 (pl) 2011-06-30

Family

ID=43646137

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04716231T PL1599211T3 (pl) 2003-03-03 2004-03-02 Zastosowanie izorhamnetyny do leczenia nastrojów i chorób depresyjnych

Country Status (6)

Country Link
US (1) US20060198914A1 (pl)
EP (1) EP1599211B1 (pl)
AT (1) ATE498397T1 (pl)
DE (1) DE502004012196D1 (pl)
PL (1) PL1599211T3 (pl)
WO (1) WO2004078189A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100367970C (zh) * 2005-01-24 2008-02-13 中国人民解放军第二军医大学 山奈酚衍生物用于制备防治痴呆药物的用途
ITMI20070555A1 (it) * 2007-03-21 2007-06-20 Giuliani Spa Composizione provvista di attivita' di inibizione sulla 5 alfa-reduttasi
CN101874822A (zh) 2009-04-27 2010-11-03 玫琳凯有限公司 植物性抗痤疮制剂
AU2011214464B2 (en) * 2010-02-11 2013-11-07 Dr. Willmar Schwabe Gmbh & Co. Kg Use of isorhamnetin triglycosides
EP3566691B1 (en) 2011-12-19 2024-04-17 Mary Kay Inc. Cosmetic method of whitening skin and evening tone with azuki beans
US9849077B2 (en) 2014-03-10 2017-12-26 Mary Kay Inc. Skin lightening compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4203159B2 (ja) * 1997-12-09 2008-12-24 株式会社林原生物化学研究所 神経機能調節剤
US6068846A (en) * 1998-08-05 2000-05-30 Melaleuca, Incorporated Methods and materials for treating depression and mood disorder
US6811795B2 (en) * 1999-11-17 2004-11-02 Tesfaye Zerihun Yigzaw Anti-cancer extracts and pharmaceutical compositions and methods

Also Published As

Publication number Publication date
US20060198914A1 (en) 2006-09-07
DE502004012196D1 (de) 2011-03-31
EP1599211B1 (de) 2011-02-16
EP1599211A1 (de) 2005-11-30
WO2004078189A1 (de) 2004-09-16
ATE498397T1 (de) 2011-03-15

Similar Documents

Publication Publication Date Title
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
EA200870019A1 (ru) Лактамовые соединения и способы их применения
DE602004024572D1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
EA200700175A1 (ru) Композиции и способы лечения воспалительных заболеваний
MXPA05010830A (es) Metodos de tratamiento que usan agentes de enlace especificos de angiopoyetina-2 humana.
SG163517A1 (en) Antiviral compounds and methods
TW200509892A (en) Novel aminobenzophenone compounds
DE60204217D1 (de) Verwendung von bioglas
ATE390928T1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
MA28106A1 (fr) Compositions immunogenes
DE602004012578D1 (de) Als inhibitoren von c-met geeignete pyrrolzusammensetzungen
EP1543158A4 (en) REGULATED APTAMER THERAPEUTICS
IL165505A0 (en) 2-heteroaryl carboxamides
TW200510449A (en) Acylated nonadepsipeptides
BR0306855A (pt) Método para o tratamento de distúrbios cognitivos
MXPA05003818A (es) Perfilamiento de la expresion genica de muestras ffpe.
PL1599211T3 (pl) Zastosowanie izorhamnetyny do leczenia nastrojów i chorób depresyjnych
ATE489948T1 (de) Behandlung von autoimmunkrankheiten
DE602004026597D1 (de) Behandlung von alzheimer-krankheit und verwandten zuständen
EA200501802A1 (ru) Сочетание аналептина модафинила и антидепрессанта для лечения депресии
ATE458495T1 (de) Therapeutische zubereitung für autoimmune erkrankungen
DE502005005652D1 (de) Heterocyclyl-substituierte nonadepsipeptide
ATE455789T1 (de) Substituierte nonadepsipeptide